Alteration of complement hemolytic activity in different trauma and sepsis models

Journal of Inflammation Research

Volumn 5, Issue 1, 2012, Pages 59-66

  Ehrnthaller, Christian ^a   Amara, Umme ^a   Weckbach, Sebastian ^a   Kalbitz, Miriam ^a   Huber Lang, Markus ^a   Bahrami, Soheyl ^b  

^a UNIVERSITY OF ULM   (Germany)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

CH50; Complement; Hemorrhagic shock; Inflammation; Ischemia reperfusion; Sepsis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT HEMOLYSIS TEST; COMPLEMENT SYSTEM; CONTROLLED STUDY; EXPERIMENTAL LIGATION; HEMOLYSIS; HEMORRHAGIC SHOCK; HYPOXEMIA; INFLAMMATION; INTESTINE ISCHEMIA; ISCHEMIA; KIDNEY ISCHEMIA; LIVER ISCHEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; SCREENING TEST; SEPSIS; SEPTIC SHOCK; TISSUE INJURY; TRAUMATIC SHOCK;

EID: 84864864483     PISSN: None     EISSN: 11787031     Source Type: Journal    
DOI: 10.2147/JIR.S31787     Document Type: Article

References (36)

1. Barrington R, Zhang M, Fischer M, Carroll MC. The role of complement in inflammation and adaptive immunity. Immunol Rev. 2001;180:5-15.
2. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol. 2004;4(2):133-142.
3. Gerard C. Complement C5a in the sepsis syndrome-too much of a good thing? N Engl J Med. 2003;348(2):167-169.
4. Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol. 2005;23:821-852.
5. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8(10):776-787.
6. Riedemann NC, Guo RF, Laudes IJ, etal. C5a receptor and thymocyte apoptosis in sepsis. Faseb J. 2002;16(8):887-888.
7. Huber-Lang M, Sarma JV, Zetoune FS, etal. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12(6):682-687.
8. Flierl MA, Perl M, Rittirsch D, etal. The role of C5a in the innate immune response after experimental blunt chest trauma. Shock. 2008;29(1):25-31.
9. Ganter MT, Brohi K, Cohen MJ, etal. Role of the alternative pathway in the early complement activation following major trauma. Shock. 2007;28(1):29-34.
10. Rutstein DD, Walker WH. Complement Activity in Pneumonia. J Clin Invest. 1942;21(3):347-352.
11. Mayer MM. Complement and complement fixation. In: Kabat EA, editor. Experimental Immunochemistry. Springfield, IL: Thomas; 1961: 133-240.
12. Salvesen B, Mollnes TE. Pathway-specific complement activity in pigs evaluated with a human functional complement assay. Mol Immunol. 2009;46(8-9):1620-1625.
13. Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S. Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock. 2004;21(1):72-76.
14. Harada N, Okajima K, Kushimoto S. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med. 1999;27(9):1958-1964.
15. Drouin SM, Kildsgaard J, Haviland J, etal. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol. 2001;166(3):2025-2032.
16. Werner ER, Bahrami S, Heller R, Werner-Felmayer G. Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feedback regulatory protein. J Biol Chem. 2002;277(12):10129-10133.
17. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94(2):331-335.
18. Bahrami S, Zimmermann K, Szelényi Z, etal. Small-volume fluid resuscitation with hypertonic saline prevents inflammation but not mortality in a rat model of hemorrhagic shock. Shock. 2006;25(3): 283-289.
19. Bumann M, Henke T, Gerngross H, Claes L, Augat P. Influence of haemorrhagic shock on fracture healing. Langenbecks Arch Surg. 2003;388(5):331-338.
20. Czermak BJ, Sarma V, Pierson CL, etal. Protective effects of C5a blockade in sepsis. Nat Med. 1999;5(7):788-792.
21. Huber-Lang MS, Riedeman NC, Sarma JV, etal. Protection of innate immunity by C5aR antagonist in septic mice. Faseb J. 2002; 16(12):1567-1574.
22. Kyriakides C, Austen W Jr, Wang Y, etal. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex. The Am J Physiol. 1999;277(6 Pt 1):C1263-C1268.
23. Leinhase I, Holers VM, Thurman JM, etal. Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci. 2006;7:55.
24. Stahl GL, Xu Y, Hao L, etal. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol. 2003;162(2): 449-455.
25. Woodruff TM, Arumugam TV, Shiels IA, Reid RC, Fairlie DP, Taylor SM. Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res. 2004;116(1):81-90.
26. Bengtsson A, Redl H, Schlag G, Högåsen K, Götze O, Mollnes TE. Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation. Scand J Immunol. 1998;48(5):509-514.
27. Mollnes TE, Redl H, Høgåsen K, etal. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol. 1993;91(2):295-300.
28. De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation. 2003;75(3):375-382.
29. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int. 2003;63(1): 134-142.
30. Ricklin D, Lambris JD. Complement-targeted therapeutics. Nat Biotechnol. 2007;25(11):1265-1275.
31. Markiewski MM, DeAngelis RA, Strey CW, etal. The regulation of liver cell survival by complement. J Immunol. 2009;182(9):5412-5418.
32. Zhao H, Montalto MC, Pfeiffer KJ, Hao L, Stahl GL. Murine model of gastrointestinal ischemia associated with complement-dependent injury. J Appl Physiol. 2002;93(1):338-345.
33. Younger JG, Sasaki N, Waite MD, etal. Detrimental effects of complement activation in hemorrhagic shock. J Appl Physiol. 2001;90(2): 441-446.
34. Curry N, Hopewell S, Doree C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92.
35. Flierl MA, Rittirsch D, Nadeau BA, etal. Functions of the complement components C3 and C5 during sepsis. Faseb J. 2008;22(10): 3483-3490.
36. Remick DG, Newcomb DE, Bolgos GL, Call DR. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs cecal ligation and puncture. Shock. 2000;13(2): 110-116.